IMMU-16. INTRA-TUMOURAL IL-12 DELIVERY ENABLES CAR T-CELL IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA

Treatment with T-cells redirected to tumour specificity with a chimeric antigen receptor (CAR) may be well suited to treat intracranial tumours due to the ability of T-cells to access the central nervous system and migrate to infiltrative sites of disease. In adult glioblastoma, a case report of loc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Agliardi, Giulia, Liuzzi, Anna Rita, Hotblack, Alastair, De Feo, Donatella, Núñez, Nicolás, Friebel, Ekaterina, Nannini, Francesco, Roberts, Thomas, Ramasawmy, Rajiv, Stowe, Cassandra, Williams, Iwan, Siow, Bernard, Lythgoe, Mark, Kalber, Tammy, Quezada, Sergio, Pule, Martin, Tugues, Sonia, Becher, Burkhard, Straathof, Karin
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715834/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.372
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares